Clinicians need to be aware of the treatment and management of melanoma across the continuum of care. As the armamentarium against advanced melanoma continues to expand, clinicians need to be informed on how to select the most appropriate therapy for each patient and to carefully monitor the unique side effects. Since there is a lack of consensus on the optimal treatment for stage III disease, clinicians need to be educated on the pros and cons of each strategy. A thorough pathology report of the primary melanoma lesion at diagnosis must not be overlooked as it forms a critical basis for prognosis prediction and treatment decisions.

This educational initiative addresses health care professionals’ need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with melanoma and related skin cancers, management of both early- and late-stage diseases, and advanced cancer.